Ernexa Therapeutics (ERNA) Q1 2023 Earnings

20MarConfirmed
Apr 22
Jul 22
Nov 22
Q1 2023
-900
-600.73
-301.47
-2.2

Details

Expected EPS
-900
Actual EPS
-465
Surprise EPS
435
Surprise Percent
+48.33%

Description

Ernexa Therapeutics (ERNA) has reported earnings of -465 per share for Q1 2023.

0 Comments

Share your thoughts